Navigation Links
VIA Pharmaceuticals Announces Grant of New Patent on Lead Compound VIA-2291
Date:2/25/2009

tients for the FDG-PET clinical trial, as well as any future clinical trial; -- failure to obtain sufficient data from enrolled patients that can be used to evaluate VIA-2291, thereby impairing the validity or statistical significance of our clinical trials; -- our ability to successfully complete our clinical trials of VIA- 2291 on expected timetables and the outcomes of such clinical trials; -- complexities in designing and implementing cardiovascular clinical trials using histological examinations, measurement of biomarkers, medical imaging and atherosclerotic plaque bioassays; -- the results of our clinical trials, including without limitation, with respect to the safety and efficacy of VIA-2291; -- if the results of the ACS and CEA studies, upon further review and analysis, are revised or negated by authorities or by later stage clinical trials; -- our ability to obtain necessary FDA approvals; -- our ability to successfully commercialize VIA-2291; -- our ability to obtain and protect our intellectual property related to our product candidates; -- our potential for future growth and the development of our product pipeline, including the THR beta agonist candidate and the other compounds licensed from Roche; -- our ability to form and maintain collaborative relationships to develop and commercialize our product candidates; -- general economic and business conditions; and -- the other risks described under Item IA "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2007 and in our Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2008 on file with the SEC.

All forward
'/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... -- About Bio-alcohols Bio-alcohols are organic ... Bio-alcohols are primarily used in the transportation sector. For ... gasoline in cars. Technavio,s analysts forecast the global bio-alcohols ... over the period 2014-2019. Covered in ... into five: transportation, infrastructure, medical, and others. Technavio,s report, ...
(Date:6/1/2015)... DUBLIN , June 1, 2015 ... has announced the addition of the "Global ... their offering.        ... Industry Report 2014 is a professional and in-depth ... industry. , ,The report provides a basic overview ...
(Date:6/1/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/9kv3rl/global ) has ... Market 2015-2019" report to their offering. ... to grow at a CAGR of 19.49% over ... of science that includes computational analysis of biological ... form and protein sequences in various biological databases. ...
(Date:6/1/2015)... , June 1, 2015  Neogen Corporation (NASDAQ: NEOG ... Sterling Test House, a leading commercial food testing laboratory based ... acquired laboratory will serve as a base for the company,s ... Sterling Test House was incorporated in 1990, ... the food safety and water quality testing for major hotels ...
Breaking Biology Technology:Global Bio-alcohols Market 2015-2019 2Global PDT Machine Industry Report 2014 2Global Bioinformatics Market 2015-2019 - Rapid Developments in Molecular Diagnostics 2Global Bioinformatics Market 2015-2019 - Rapid Developments in Molecular Diagnostics 3Neogen acquires India food safety company 2
... structures look like fragments of nanoscopic pearl necklaces. In ... together by means of a special fullerene-binding molecule. Spanish ... the latest issue of the journal Angewandte Chemie. , ... atoms whose linkages resemble the five- and six-sided leather ...
... BERLIN, November 30 Berlin Heart today announced ... for its EXCOR(R),Paediatric VAD, a mechanical cardiac support ... heart failure., The multi-center IDE study is ... the EXCOR(R) Paediatric VAD to support Paediatric,patients. The ...
... ABR-Affinity,BioReagents, a leading global antibody manufacturer, announced today the,company,s ... Annual Meeting in Washington D.C., December 1 - 5, ... most significant of the year in terms,of contact with ... in,this exciting area of research," said Ken Wilczek, President ...
Cached Biology Technology:Berlin Heart Enrolls First Patient in US Multi-Center EXCOR(R) Pediatric VAD IDE Study 2Berlin Heart Enrolls First Patient in US Multi-Center EXCOR(R) Pediatric VAD IDE Study 3ABR-Affinity BioReagents to Exhibit at ASCB in Washington D.C., December 1 - 5, 2007 2
(Date:5/25/2015)... 2015  Australia,s market for wearable technologies is considered ... the advent of several trials and prototypes. The release ... expected to ignite interest in wearables as well as ... . This in turn will spur greater innovation ... partnerships amongst vendors and distributors. Photo ...
(Date:5/22/2015)... According to a new market ... Thermal, Emotion, Forensic), by Software (Middleware, Databases), by Hardware (Cameras, ... and Home) - Global Forecast to 2020", published by ... in 2015 to $6.19 Billion by 2020, at a ... data Tables and   43 Figures spread through 140 ...
(Date:5/21/2015)... , May 21, 2015 The ... potential of music for health, today announced a collaborative ... . The partnership will center on collaboration on original ... a first step in the collaboration, The Sync Project ... on "Music as Medicine" in the 2015-2016 academic year.  ...
Breaking Biology News(10 mins):Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3
... Jennifer L. Howse, President of the March of Dimes Foundation, ... the nation,s premier advisory group on improving health. ... honor, and it acknowledges the achievements of Dr. Howse,s career, ... Dimes to improving maternal, infant and child health," said Richard ...
... of Missouri indicates that Atlantic Ocean temperatures during the ... by circulation in the deep ocean. These changes in ... understand the consequences of modern increases in greenhouse gases. ... greenhouse climate intervals so that we can understand better ...
... MA (Oct 27, 2011)Researchers have built a map that shows ... with each other . This is the largest and ... how approximately 5000, or one third, of the proteins cooperate ... for decades, trying to unravel the precise connections among the ...
Cached Biology News:Dr. Jennifer L. Howse elected to Institute of Medicine 2Prehistoric greenhouse data from ocean floor could predict earth's future, MU study finds 2Researchers build largest protein interaction map to date 2Researchers build largest protein interaction map to date 3
... Cloning is the most ... cloning PCR products. TOPO ... Blunt TOPO vectors are ... with topoisomerase I. This ...
ready-to-use solution...
... MS/MS analysis & visualization ... across multiple samples. Combine ... for increased confidence. Get ... information from your MS/MS ...
... Clone/PAD: ZMD.467. Immunogen: Synthetic ... of the human rat mouse dog ... Specific for the human occludin protein. ... cell lysates). Reactivity with rat ...
Biology Products: